DK0701612T3 - Immunogent præparat af OspC-antigenvacciner til forebyggelse og behandling af Lyme sygdom og rekombinantmetode til fremsti - Google Patents
Immunogent præparat af OspC-antigenvacciner til forebyggelse og behandling af Lyme sygdom og rekombinantmetode til fremstiInfo
- Publication number
- DK0701612T3 DK0701612T3 DK94915562T DK94915562T DK0701612T3 DK 0701612 T3 DK0701612 T3 DK 0701612T3 DK 94915562 T DK94915562 T DK 94915562T DK 94915562 T DK94915562 T DK 94915562T DK 0701612 T3 DK0701612 T3 DK 0701612T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- prevention
- treatment
- lyme disease
- ospc
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5386393A | 1993-04-29 | 1993-04-29 | |
| PCT/EP1994/001365 WO1994025596A2 (en) | 1993-04-29 | 1994-04-29 | IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0701612T3 true DK0701612T3 (da) | 1998-09-21 |
Family
ID=21987063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94915562T DK0701612T3 (da) | 1993-04-29 | 1994-04-29 | Immunogent præparat af OspC-antigenvacciner til forebyggelse og behandling af Lyme sygdom og rekombinantmetode til fremsti |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0701612B1 (hu) |
| JP (1) | JPH08509371A (hu) |
| AT (1) | ATE162550T1 (hu) |
| AU (1) | AU683260B2 (hu) |
| CA (1) | CA2161534A1 (hu) |
| CZ (1) | CZ289212B6 (hu) |
| DE (1) | DE69408135T2 (hu) |
| DK (1) | DK0701612T3 (hu) |
| ES (1) | ES2114687T3 (hu) |
| FI (1) | FI955150L (hu) |
| HR (1) | HRP940279B1 (hu) |
| HU (1) | HU217024B (hu) |
| NO (1) | NO954318L (hu) |
| PL (1) | PL178775B1 (hu) |
| SK (1) | SK279968B6 (hu) |
| WO (1) | WO1994025596A2 (hu) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5915049A (en) * | 1992-02-25 | 1999-06-22 | Pfu Limited | Binarization system for an image scanner |
| US7008625B2 (en) | 1993-11-01 | 2006-03-07 | Research Foundation Of The State University Of New York | Recombinant constructs of Borrelia burgdorferi |
| US6716574B2 (en) | 1996-05-02 | 2004-04-06 | Dako A/S | Osp-C derived peptide fragments |
| DE69718903T2 (de) * | 1996-05-02 | 2003-12-04 | Dakocytomation Denmark A/S, Glostrup | Verwendung von aus osp-c abgeleiteten peptidefragmenten für diagnostische methoden |
| US5846946A (en) * | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
| AT405940B (de) * | 1996-06-21 | 1999-12-27 | Immuno Ag | Verfahren zur gewinnung und reinigung von rekombinantem, nicht-lipidiertem osp-protein |
| DE19629543C2 (de) * | 1996-07-22 | 1999-02-11 | Immuno Ag | Immunassay zum Nachweis von anti-B. burgdorferi Antikörpern und Verfahren zur Serodiagnose bei Lyme Borreliose, diagnostische Mittel und Testkits zur Durchführung der Verfahren |
| DE19740735A1 (de) | 1997-09-16 | 1999-03-18 | Max Planck Gesellschaft | Arzneimittel zur Therapie einer manifesten Lyme-Borreliose |
| JP3631960B2 (ja) * | 1998-07-31 | 2005-03-23 | ガンダーセン ルテラン メディカル ファウンデイション インコーポレイテッド | ワクチンとしてのボレリアブルグドルフェリ外部表面タンパク質ｃ（ｏｓｐｃ）のボレリアシダルエピトープの使用 |
| WO2000078966A1 (en) * | 1999-06-18 | 2000-12-28 | Research Foundation Of State University Of New York | Groups of borrelia burgdorferi and borrelia afzelii that cause lyme disease in humans |
| WO2002016421A2 (en) | 2000-08-18 | 2002-02-28 | Research Foundation Of The State University Of New York | Altered ospa of borrelia burgdorferi |
| GB2414667A (en) | 2004-06-03 | 2005-12-07 | Isis Innovation | Vaccine compositions of N. meningitidis PorA and FetA antigens |
| EP1957520A4 (en) * | 2005-11-29 | 2009-05-27 | Univ Virginia Commonwealth | POLYVALENTIC CHIMERIC OSPC VACCINOGEN AND DIAGNOSTIC ANTIGEN |
| JP5177824B2 (ja) * | 2006-11-03 | 2013-04-10 | シェーリング−プラウ・リミテッド | イヌのライム病のワクチン |
| CZ301244B6 (cs) * | 2007-11-14 | 2009-12-16 | Bioveta, A.S. | Univerzální vakcína k lécbe a prevenci Lymeské borreliózy pro humánní a veterinární použití a zpusob její výroby |
| CZ301548B6 (cs) * | 2008-08-20 | 2010-04-14 | Bittner@Libor | Univerzální preparát ke zvýšení obranyschopnosti, prevenci, profylaxi a lécbe Lymeské boreliózy pro humánní a veterinární použití, zpusob jeho výroby a použití |
| WO2025015077A1 (en) * | 2023-07-10 | 2025-01-16 | Dynavax Technologies Corporation | Lyme disease vaccines comprising an adjuvant and borrelia outer surface protein a and c antigens |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6221363B1 (en) * | 1991-07-11 | 2001-04-24 | Baxter Aktiengesellschaft | Vaccine for the prevention of lyme disease |
-
1994
- 1994-04-29 PL PL94311301A patent/PL178775B1/pl not_active IP Right Cessation
- 1994-04-29 AU AU67229/94A patent/AU683260B2/en not_active Ceased
- 1994-04-29 CA CA002161534A patent/CA2161534A1/en not_active Abandoned
- 1994-04-29 SK SK1341-95A patent/SK279968B6/sk unknown
- 1994-04-29 HU HU9502002A patent/HU217024B/hu not_active IP Right Cessation
- 1994-04-29 DE DE69408135T patent/DE69408135T2/de not_active Expired - Fee Related
- 1994-04-29 EP EP94915562A patent/EP0701612B1/en not_active Expired - Lifetime
- 1994-04-29 WO PCT/EP1994/001365 patent/WO1994025596A2/en active IP Right Grant
- 1994-04-29 AT AT94915562T patent/ATE162550T1/de not_active IP Right Cessation
- 1994-04-29 CZ CZ19952839A patent/CZ289212B6/cs not_active IP Right Cessation
- 1994-04-29 JP JP6523899A patent/JPH08509371A/ja not_active Ceased
- 1994-04-29 DK DK94915562T patent/DK0701612T3/da active
- 1994-04-29 HR HR940279A patent/HRP940279B1/xx not_active IP Right Cessation
- 1994-04-29 ES ES94915562T patent/ES2114687T3/es not_active Expired - Lifetime
-
1995
- 1995-10-27 FI FI955150A patent/FI955150L/fi not_active IP Right Cessation
- 1995-10-27 NO NO954318A patent/NO954318L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69408135D1 (de) | 1998-02-26 |
| CZ289212B6 (cs) | 2001-12-12 |
| NO954318L (no) | 1995-12-29 |
| FI955150A0 (fi) | 1995-10-27 |
| HU217024B (hu) | 1999-11-29 |
| PL311301A1 (en) | 1996-02-05 |
| ATE162550T1 (de) | 1998-02-15 |
| SK279968B6 (sk) | 1999-06-11 |
| AU683260B2 (en) | 1997-11-06 |
| CZ283995A3 (en) | 1996-03-13 |
| HRP940279B1 (en) | 2000-12-31 |
| HUT72923A (en) | 1996-06-28 |
| SK134195A3 (en) | 1996-05-08 |
| JPH08509371A (ja) | 1996-10-08 |
| DE69408135T2 (de) | 1998-06-10 |
| AU6722994A (en) | 1994-11-21 |
| FI955150L (fi) | 1995-12-28 |
| CA2161534A1 (en) | 1994-11-10 |
| WO1994025596A2 (en) | 1994-11-10 |
| EP0701612B1 (en) | 1998-01-21 |
| EP0701612A1 (en) | 1996-03-20 |
| ES2114687T3 (es) | 1998-06-01 |
| PL178775B1 (pl) | 2000-06-30 |
| HU9502002D0 (en) | 1995-08-28 |
| NO954318D0 (no) | 1995-10-27 |
| HRP940279A2 (en) | 1997-10-31 |
| WO1994025596A3 (en) | 1994-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0701612T3 (da) | Immunogent præparat af OspC-antigenvacciner til forebyggelse og behandling af Lyme sygdom og rekombinantmetode til fremsti | |
| NO913518L (no) | Vaksiner for ikke typebestembar haemophilus influenzae. | |
| DK0598816T3 (da) | Osp A-proteiner fra Borrelia Burgdorferi-undergrupper, hvilke proteiner koder for gener og vacciner | |
| DK1398379T3 (da) | Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose | |
| DK96493D0 (da) | Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden | |
| SG152917A1 (en) | Neisseria meningitidis antigens | |
| KR890701125A (ko) | 무병원성 미생물 및 이의 용도 | |
| DE69929444D1 (de) | Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung | |
| NZ331651A (en) | BSW17 peptide immunogens for vaccination against and treatment of allergy | |
| GB9626483D0 (en) | Helicobacter proteins and vaccines | |
| ATE475668T1 (de) | Immunisierung durch impfung von dns transkriptionseinheit | |
| DK0555276T3 (da) | Immunogene komplekser, især iscomer | |
| HUP9903770A2 (hu) | Eljárások és készítmények többepitópos antigének konformációjának megváltoztatására immunválasz kiváltása céljából | |
| DK0880360T3 (da) | Hidtil ukendte fremgangsmåder til vaccination og vacciner dertil, hvilke vacciner omfatter en nucleinsyre, der koder en første epitop, og et peptid, der indeholder en sekundær epitop | |
| DK1238086T3 (da) | Vaccine til forögelse af immunreaktioner på herpes simplex virus | |
| DK218886A (da) | Tvaerreaktive og beskyttende epitoper af circumsporozoit-proteiner | |
| DK0792347T3 (da) | Fremgangsmåder til fremstilling af forbedrede antigene Heliobacter sp. og vacciner omfattende samme | |
| WO2000039301A3 (en) | Methods for using mycobacterium tuberculosis molecules as immunological adjuvants | |
| IE860758L (en) | Anaplasma marginale subunit antigen for vaccination and¹diagnosis | |
| NO973753D0 (no) | Helicobacter pylori antigen | |
| EP1502602A3 (en) | Methods for therapeutic vaccination | |
| AR020852A1 (es) | Antigenos de vacuna de leptospira para la prevencion de leptospirosis | |
| HUP0002752A2 (hu) | Egy szekréciós vektor alkalmazása termékenység-szabályozásra orális vakcinálással | |
| SE9600646D0 (sv) | Vaccin |